
Developer of clinical stage drug discovery intended for treatment of fibrosis and rare diseases. The company's clinical stage drug discovery develop an innovative internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetic targets and nuclear receptors assisting its customers with delivering breakthrough therapies in the area of oncology, fibrosis and rare diseases. Read More